As we emerge from the 2024 election, Julieta Smith, SVP, Strategy, shares her POV on how we can brace for change in healthcare communications. - With $1.9T spent on healthcare in 2023, expect continued drug price negotiations and cost-control efforts. - The president elect’s platform signals a market-driven ACA replacement and Medicaid block grants, which could reshape coverage, especially for low-income households. - Deregulation ideas, potential FDA/CDC leadership shifts, and U.S.-China policy shifts could affect drug access and healthcare systems. Read the full insights here: https://bit.ly/3ZhsZo0
